Skip to main content
. 2021 May 13:1–11. doi: 10.1080/07391102.2021.1922310

Figure 6.

Figure 6.

DCCM analysis – (a) Apo, (b) Lopinavir, (c) Nelfinavir, (d) O6K, (e) Ritonavir, (f) Saquinavir, (g) Sofosbuvir, (h) Tenofovir, (i)Terlipressin.